04/26/2006 On April 25, 2006, the U.S. District Court for the District of Arizona issued a 15-page opinion denying a motion for a preliminary injunction against RMMS’s client, Prasco, LLC. After briefing and a hearing before the Court, RMMS defeated Plaintiff Medicis Pharmaceutical Corporation’s motion, which called for the removal of Prasco’s product from the market. As a result, Prasco was able to keep its generic product on the market pending the outcome of the underlying patent litigation against Medicis.
Please see ‘Pressure Rises for FDA, Congress in Latest Drug Duel’ by Christine Hines of the Legal Times.